

Representing investor in fraudulent misrepresentation
Representing a private investor in a claim before the Singapore High Court against prominent Asian venture capital group for fraudulent misrepresentation.
Sep 11 min read


Representing luxury resort group founder in shareholder oppression claim
Acted for the founder of a luxury resort group in the Maldives (business worth almost US$300 million) in commencing a shareholder oppression claim against the group’s private equity investor before the Singapore International Commercial Court.
Jun 301 min read


Singapore Counsel to Meesho in Acquisition of Kirana Club
Collyer Law acted as Singapore counsel to Meesho, one of India's leading e-commerce marketplaces, in connection with its proposed USD 23 million acquisition of Kirana Club Pte Ltd, a Singapore-incorporated B2B commerce platform serving kirana retailers across India, and a concurrent direct stake in Kirana Club's Indian subsidiary, Retail Pulse Labs Private Limited. Our role covered the Singapore law aspects of the transaction, including red-flag legal due diligence on the Sin
Jun 241 min read


Advising Milexia in connection with acquisition of Syratron
Advised Milexia Group, a leading French technology group, on the Singapore law aspects of its acquisition of Syratron Technologies, as part of its proposed 100% acquisition of the target group. The transaction involved a complex India-led holding structure with a Singapore subsidiary, and our role included advising on cross-border structuring considerations, legal due diligence, the reorganisation of the Singapore entity within the wider group architecture, regulatory and cor
Feb 261 min read


Leading Dental Care Company in Connection with the Acquisition of a Pan-Asian Clear Aligner Company
Collyer Law acted as Singapore counsel to MakeO (dba Toothsi), a leading Indian dental technology company in connection with its 100% acquisition of Zenyum, creating a leading pan-Asian clear aligner platform. The transaction involved the acquisition of a Singapore-headquartered, pan-Asia consumer healthcare business by an Indian strategic, with operations and regulatory touchpoints across Singapore, Taiwan, Thailand, South Korea, Hong Kong, Vietnam, Japan, Malaysia and Indo
Jan 191 min read


















